Skip to main content
Top

Angiogenesis

Issue 2/2014

Special Issue: Lymphangiogenesis in Inflammation

Content (10 Articles)

Editorial

Introduction to the special issue on lymphangiogenesis in inflammation

Melody A. Swartz, Gwendalyn J. Randolph

Review Paper

Inflammation-induced lymphangiogenesis and lymphatic dysfunction

Shan Liao, Pierre-Yves von der Weid

Review Paper

Control of dendritic cell trafficking in lymphatics by chemokines

Louise A. Johnson, David G. Jackson

Open Access Original Paper

Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis

Witold W. Kilarski, Angelika Muchowicz, Malgorzata Wachowska, Renata Mężyk-Kopeć, Jakub Golab, Melody A. Swartz, Patrycja Nowak-Sliwinska

Original Paper

Lymphatic vessels: new targets for the treatment of inflammatory diseases

Lothar C. Dieterich, Catharina D. Seidel, Michael Detmar

Original Paper

Inflammatory lymphangiogenesis: cellular mediators and functional implications

Kar Wai Tan, Shu Zhen Chong, Véronique Angeli

Original Paper

The inflammatory response of lymphatic endothelium

David Aebischer, Maria Iolyeva, Cornelia Halin

Original Paper

The effects of inflammatory cytokines on lymphatic endothelial barrier function

Walter E. Cromer, Scott D. Zawieja, Binu Tharakan, Ed W. Childs, M. Karen Newell, David C. Zawieja

Original Paper

Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells

Yu-Han Huang, Hung-Yu Yang, Ya-Fen Hsu, Pei-Ting Chiu, George Ou, Ming-Jen Hsu

Original Paper

Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells

Cristina T. Kesler, Angera H. Kuo, Hon-Kit Wong, David J. Masuck, Jennifer L. Shah, Kevin R. Kozak, Kathryn D. Held, Timothy P. Padera

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine